Alzheimer’s Disease Therapeutics and Diagnostics Market, Global Outlook and Forecast 2022-2028

April 2022 | 69 pages | ID: A62618F8D76CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Alzheimer’s Disease Therapeutics and Diagnostics in Global, including the following market information:

Global Alzheimer’s Disease Therapeutics and Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Alzheimer’s Disease Therapeutics and Diagnostics market was valued at 6787.4 million in 2021 and is projected to reach US$ 8715 million by 2028, at a CAGR of 3.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Alzheimer’s Disease Therapeutics and Diagnostics include Pfizer, Eisai, Novartis, Forest Laboratories, TauRx Therapeutics, AC Immune, Johnson & Johnson. and H. Lundbeck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alzheimer’s Disease Therapeutics and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Alzheimer’s Disease Therapeutics and Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Alzheimer’s Disease Therapeutics and Diagnostics Market Segment Percentages, by Type, 2021 (%)

• Diagnostics
• Treatment

Global Alzheimer’s Disease Therapeutics and Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Alzheimer’s Disease Therapeutics and Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Marketed Drugs
• Pipeline Drugs

Global Alzheimer’s Disease Therapeutics and Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Alzheimer’s Disease Therapeutics and Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Alzheimer’s Disease Therapeutics and Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Alzheimer’s Disease Therapeutics and Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Eisai
• Novartis
• Forest Laboratories
• TauRx Therapeutics
• AC Immune
• Johnson & Johnson.
• H. Lundbeck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Alzheimer’s Disease Therapeutics and Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size: 2021 VS 2028
2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Alzheimer’s Disease Therapeutics and Diagnostics Players in Global Market
3.2 Top Global Alzheimer’s Disease Therapeutics and Diagnostics Companies Ranked by Revenue
3.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Alzheimer’s Disease Therapeutics and Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Alzheimer’s Disease Therapeutics and Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alzheimer’s Disease Therapeutics and Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Alzheimer’s Disease Therapeutics and Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Alzheimer’s Disease Therapeutics and Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 Diagnostics
  4.1.3 Treatment
4.2 By Type - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2021 & 2028
  5.1.2 Marketed Drugs
  5.1.3 Pipeline Drugs
5.2 By Application - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2017-2028
  6.3.2 US Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.3.3 Canada Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.3.4 Mexico Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2017-2028
  6.4.2 Germany Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.4.3 France Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.4.4 U.K. Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.4.5 Italy Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.4.6 Russia Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.4.8 Benelux Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2017-2028
  6.5.2 China Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.5.3 Japan Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.5.4 South Korea Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.5.6 India Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2017-2028
  6.6.2 Brazil Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.6.3 Argentina Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2017-2028
  6.7.2 Turkey Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.7.3 Israel Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028
  6.7.5 UAE Alzheimer’s Disease Therapeutics and Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Major Product Offerings
  7.1.4 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Eisai
  7.2.1 Eisai Corporate Summary
  7.2.2 Eisai Business Overview
  7.2.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Major Product Offerings
  7.2.4 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 Eisai Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Major Product Offerings
  7.3.4 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Forest Laboratories
  7.4.1 Forest Laboratories Corporate Summary
  7.4.2 Forest Laboratories Business Overview
  7.4.3 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Major Product Offerings
  7.4.4 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Forest Laboratories Key News
7.5 TauRx Therapeutics
  7.5.1 TauRx Therapeutics Corporate Summary
  7.5.2 TauRx Therapeutics Business Overview
  7.5.3 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Major Product Offerings
  7.5.4 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 TauRx Therapeutics Key News
7.6 AC Immune
  7.6.1 AC Immune Corporate Summary
  7.6.2 AC Immune Business Overview
  7.6.3 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Major Product Offerings
  7.6.4 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 AC Immune Key News
7.7 Johnson & Johnson.
  7.7.1 Johnson & Johnson. Corporate Summary
  7.7.2 Johnson & Johnson. Business Overview
  7.7.3 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Major Product Offerings
  7.7.4 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 Johnson & Johnson. Key News
7.8 H. Lundbeck
  7.8.1 H. Lundbeck Corporate Summary
  7.8.2 H. Lundbeck Business Overview
  7.8.3 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Major Product Offerings
  7.8.4 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 H. Lundbeck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Alzheimer’s Disease Therapeutics and Diagnostics Market Opportunities & Trends in Global Market
Table 2. Alzheimer’s Disease Therapeutics and Diagnostics Market Drivers in Global Market
Table 3. Alzheimer’s Disease Therapeutics and Diagnostics Market Restraints in Global Market
Table 4. Key Players of Alzheimer’s Disease Therapeutics and Diagnostics in Global Market
Table 5. Top Alzheimer’s Disease Therapeutics and Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Alzheimer’s Disease Therapeutics and Diagnostics Product Type
Table 9. List of Global Tier 1 Alzheimer’s Disease Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alzheimer’s Disease Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Alzheimer’s Disease Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Product Offerings
Table 32. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Product Offerings
Table 35. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Product Offerings
Table 38. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Forest Laboratories Corporate Summary
Table 40. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Product Offerings
Table 41. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. TauRx Therapeutics Corporate Summary
Table 43. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Product Offerings
Table 44. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. AC Immune Corporate Summary
Table 46. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Product Offerings
Table 47. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson. Corporate Summary
Table 49. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Product Offerings
Table 50. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. H. Lundbeck Corporate Summary
Table 52. H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Product Offerings
Table 53. H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Alzheimer’s Disease Therapeutics and Diagnostics Segment by Type in 2021
Figure 2. Alzheimer’s Disease Therapeutics and Diagnostics Segment by Application in 2021
Figure 3. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alzheimer’s Disease Therapeutics and Diagnostics Revenue in 2021
Figure 8. By Type - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Alzheimer’s Disease Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)